Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 62 for parkinson's

Edit search filters
  1. Efficacy of Extended Melatonin on sleep cycle in patients with PD and RBD.

    Jacksonville, FL

  2. Real-Time Feedback Training to Improve Gait and Posture in People with Parkinson’s Disease

    Scottsdale/Phoenix, AZ

  3. A Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects with Lewy Body Dementia

    Rochester, MN

  4. Submandibular Gland Needle Core Biopsy and Skin Punch Biopsy as Tissue Biomarkers for the Diagnosis and Monitoring of Disease Progression of Parkinson’s Disease and REM Sleep Behavior Disorder

    Scottsdale/Phoenix, AZ

  5. A Study to Evaluate Caregiver Connections via Technology for Patients with Alzheimer's and Other Types of Dementia

    Rochester, MN

  6. DaTSCAN Imaging in Aging and Neurodegenerative Disease

    Rochester, MN, Jacksonville, FL

  7. Altropane Dose for Imaging Patients With Suspected Parkinson's Disease

    Rochester, MN

  8. A Study of BHV-3241 in Subjects with Multiple System Atrophy

    Rochester, MN

  9. A Study of Rifampicin in Multiple System Atrophy

    Rochester, MN, Jacksonville, FL

  10. A Study of BHV-3241 in Subjects with Multiple System Atrophy

    Jacksonville, FL

.

Mayo Clinic Footer